Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov 23:9:974123.
doi: 10.3389/fcvm.2022.974123. eCollection 2022.

Women at heart: Introducing gender cardio-oncology

Maria Laura Canale  1 , Irma Bisceglia  2 , Giuseppina Gallucci  3 , Giulia Russo  4 , Andrea Camerini  5 , Stefania Angela Di Fusco  6 , Andrea Paccone  7 , Massimiliano Camilli  8   9 , Damiana Fiscella  10 , Chiara Lestuzzi  11 , Fabio Maria Turazza  12 , Michele Massimo Gulizia  10 , Daniela Pavan  13 , Nicola Maurea  7 , Domenico Gabrielli  14 , Fabrizio Oliva  15 , Furio Colivicchi  6
Affiliations
Review

Women at heart: Introducing gender cardio-oncology

Maria Laura Canale et al. Front Cardiovasc Med. .

Abstract

As cardio-oncology imposed itself as the reference specialty for a comprehensive cardiovascular approach to all patients with cancer, a more specific and careful cardiac evaluation of women entering their journey into cancer care is needed. Gender medicine refers to the study of how sex-based biological and gender-based socioeconomic and cultural differences influence people's health. Gender-related aspects could account for differences in the development, progression, and clinical signs of diseases as well as in the treatment of adverse events. Gender also accounts for major differences in access to healthcare. As for medicine and healthcare in general, gender-related characteristics have gained significance in cardio-oncology and should no longer be neglected in both clinical practice and research. We aimed to review the most relevant cardiovascular issues in women related to the cardio-oncology approach to offer a specific gender-related point of view for clinicians involved in the care process for both cancer and cardiovascular disease.

Keywords: anthracyclines; cardio-oncology; gender medicine; immunotherapy; radiotherapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Factors influencing sex and gender-related cardio-oncology issues (Panel A) and how to address them (Panel B).
See this image and copyright information in PMC

References

    1. Zamorano JL, Lancellotti P, Rodriguez Mungnoz D, Aboyans V, Asteggiano R, Galderisi M, et al. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines. Eur Heart J. (2016) 37:2768–801. 10.1093/eurheartj/ehw211 - DOI - PubMed
    1. Curigliano G, Lenihan D, Fradley M, Ganatra S, Barac A, Blaes A, et al. Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations. Ann Oncol. (2020) 31:171–90. 10.1016/j.annonc.2019.10.023 - DOI - PMC - PubMed
    1. Armenian SH, Lacchetti C, Barac A, Carver J, Constine LS, Denduluri N, et al. Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American society of clinical oncology clinical practice guideline. J Clin Oncol. (2017) 35:893–911. 10.1200/JCO.2016.70.5400 - DOI - PubMed
    1. Hajjar LA, Mathias C. Cardio-oncology in Brazil: the dimensions of a new era in the care of patients. JACC CardioOncol. (2020) 2:340–2. 10.1016/j.jaccao.2020.05.004 - DOI - PMC - PubMed
    1. Rassaf T, Totzeck M, Backs J, Bokemeyer C, Hallek M, Hilfiker-Kleiner D, et al. Onco-cardiology: consensus paper of the German cardiac society, the German society for pediatric cardiology and congenital heart defects and the German society for hematology and medical oncology. Clin Res Cardiol. (2020) 109:1197–222. 10.1007/s00392-020-01636-7 - DOI - PMC - PubMed